Terabe; Masaki

Patent Applications and Registrations

Patent applications and USPTO patent grants for Terabe; Masaki.The latest application filed is for "3-o-sulfo-galactosylceramide analogs as activators of type ii nkt cells and uses thereof".

Company Profile

1.9.15

Terabe; Masaki - Potomac MD
Terabe; Masaki - Bethesda MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions and methods for the treatment of HER2-expressing solid tumors Grant 11,266,726 - Wood , et al. March 8, 2	2022-03-08
3-o-sulfo-galactosylceramide Analogs As Activators Of Type Ii Nkt Cells And Uses Thereof App 20210023110 - Pasquet; Lise H. ; et al.	2021-01-28
Multi-epitope TARP peptide vaccine and uses thereof Grant 10,286,050 - Wood , et al.	2019-05-14
Compositions And Methods For The Treatment Of Her2-expressing Solid Tumors App 20180344828 - Wood; Lauren V. ; et al.	2018-12-06
Beta-mannosylceramide and stimulation of NKT cell anti-tumor immunity Grant 9,517,243 - Berzofsky , et al. December 13, 2	2016-12-13
Multi-epitope Tarp Peptide Vaccine And Uses Thereof App 20160310585 - Wood; Lauren V. ; et al.	2016-10-27
Immunogenic POTE peptides and methods of use Grant 9,394,352 - Berzofsky , et al. July 19, 2	2016-07-19
Beta-mannosylceramide And Stimulation Of Nkt Cell Anti-tumor Immunity App 20160101123 - Berzofsky; Jay A . ; et al.	2016-04-14
.beta.-mannosylceramide and stimulation of NKT cell anti-tumor immunity Grant 9,168,291 - Berzofsky , et al. October 27, 2	2015-10-27
Immunogenic Pote Peptides And Methods Of Use App 20150010590 - Berzofsky; Jay A. ; et al.	2015-01-08
Beta-mannosylceramide And Stimulation Of Nkt Cell Anti-tumor Immunity App 20140348786 - Berzofsky; Jay A. ; et al.	2014-11-27
Immunogenic POTE peptides and methods of use Grant 8,871,902 - Berzofsky , et al. October 28, 2	2014-10-28
.beta.-mannosylceramide and stimulation of NKT cell anti-tumor immunity Grant 8,835,613 - Berzofsky , et al. September 16, 2	2014-09-16
Immunogenic Peptides of Xage-1 App 20130171178 - Berzofsky; Jay A. ; et al.	2013-07-04
Immunogenic Pote Peptides And Methods Of Use App 20130039936 - Berzofsky; Jay A. ; et al.	2013-02-14
Beta-mannosylceramide And Stimulation Of Nkt Cell Anti-tumor Immunity App 20130039886 - Berzofsky; Jay A. ; et al.	2013-02-14
Treatment Of Cancer Via Targeting Of Il-13 Receptor-alpha2 App 20110268749 - Strober; Warren ; et al.	2011-11-03
Synergistic Effect of Tgf-Beta Blockade and Immunogenic Agents on Tumors App 20080267964 - Terabe; Masaki ; et al.	2008-10-30
Methods to prevent tumor recurrence by blockade of tgf-beta App 20060057145 - Berzofsky; JayA ; et al.	2006-03-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.